BNP Paribas Financial Markets’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $134K | Sell |
3,423
-2,832
| -45% | -$87.3K | ﹤0.01% | 4393 |
|
|
2026
Q1 | $169K | Buy |
6,255
+4,030
| +181% | +$135K | ﹤0.01% | 4126 |
|
|
2025
Q4 | $95.3K | Sell |
2,225
-1,719
| -44% | -$64.8K | ﹤0.01% | 4397 |
|
|
2025
Q3 | $112K | Buy |
3,944
+2,056
| +109% | +$61.5K | ﹤0.01% | 4241 |
|
|
2025
Q2 | $35.4K | Sell |
1,888
-28,963
| -94% | -$549K | ﹤0.01% | 4377 |
|
|
2025
Q1 | $555K | Sell |
30,851
-50
| -0.2% | -$1.01K | ﹤0.01% | 3131 |
|
|
2024
Q4 | $520K | Buy |
30,901
+9,893
| +47% | +$190K | ﹤0.01% | 3278 |
|
|
2024
Q3 | $340K | Buy |
21,008
+19,391
| +1,199% | +$228K | ﹤0.01% | 3019 |
|
|
2024
Q2 | $13.3K | Sell |
1,617
-23,679
| -94% | -$248K | ﹤0.01% | 3697 |
|
|
2024
Q1 | $374K | Buy |
25,296
+4,923
| +24% | +$66.3K | ﹤0.01% | 2997 |
|
|
2023
Q4 | $295K | Buy |
20,373
+2,591
| +15% | +$26.5K | ﹤0.01% | 3069 |
|
|
2023
Q3 | $192K | Buy |
17,782
+13,191
| +287% | +$159K | ﹤0.01% | 3109 |
|
|
2023
Q2 | $59.2K | Sell |
4,591
-2,334
| -34% | -$31.6K | ﹤0.01% | 3419 |
|
|
2023
Q1 | $91.4K | Sell |
6,925
-3,141
| -31% | -$49.9K | ﹤0.01% | 3338 |
|
|
2022
Q4 | $151K | Buy |
10,066
+484
| +5% | +$4.44K | ﹤0.01% | 3101 |
|
|
2022
Q3 | $113K | Buy |
9,582
+5,978
| +166% | +$80.9K | ﹤0.01% | 3720 |
|
|
2022
Q2 | $40.7K | Buy |
3,604
+2,210
| +159% | +$44.4K | ﹤0.01% | 3600 |
|
|
2022
Q1 | $41.7K | Sell |
1,394
-2,060
| -60% | -$55.8K | ﹤0.01% | 3589 |
|
|
2021
Q4 | $91.5K | Buy |
3,454
+430
| +14% | +$13K | ﹤0.01% | 3621 |
|
|
2021
Q3 | $110K | Buy |
3,024
+2,375
| +366% | +$93.5K | ﹤0.01% | 3233 |
|
|
2021
Q2 | $28.1K | Sell |
649
-3,298
| -84% | -$125K | ﹤0.01% | 3449 |
|
|
2021
Q1 | $135K | Buy |
3,947
+1,883
| +91% | +$74.6K | ﹤0.01% | 3215 |
|
|
2020
Q4 | $72.2K | Sell |
2,064
-2,154
| -51% | -$62.4K | ﹤0.01% | 3378 |
|
|
2020
Q3 | $101K | Buy |
4,218
+3,630
| +617% | +$89.1K | ﹤0.01% | 3112 |
|
|
2020
Q2 | $10.8K | Sell |
588
-4,584
| -89% | -$82.5K | ﹤0.01% | 3676 |
|
|
2020
Q1 | $80.7K | Buy |
5,172
+3,239
| +168% | +$68.9K | ﹤0.01% | 3318 |
|
|
2019
Q4 | $41.4K | Sell |
1,933
-742
| -28% | -$15.3K | ﹤0.01% | 3739 |
|
|
2019
Q3 | $50K | Buy |
2,675
+819
| +44% | +$16.9K | ﹤0.01% | 3477 |
|
|
2019
Q2 | $48.4K | Sell |
1,856
-1,638
| -47% | -$37K | ﹤0.01% | 3435 |
|
|
2019
Q1 | $89.8K | Buy |
3,494
+3,097
| +780% | +$70.8K | ﹤0.01% | 3183 |
|
|
2018
Q4 | $9.12K | Sell |
397
-478
| -55% | -$13.5K | ﹤0.01% | 3383 |
|
|
2018
Q3 | $28.1K | Hold |
875
| – | – | ﹤0.01% | 3276 |
|
|
2018
Q2 | $24.8K | Sell |
875
-2,180
| -71% | -$77.6K | ﹤0.01% | 3409 |
|
|
2018
Q1 | $108K | Buy |
3,055
+51
| +2% | +$2.04K | ﹤0.01% | 3139 |
|
|
2017
Q4 | $117K | Buy |
3,004
+2,058
| +218% | +$78.3K | ﹤0.01% | 3222 |
|
|
2017
Q3 | $24K | Sell |
946
-271
| -22% | -$6.59K | ﹤0.01% | 3502 |
|
|
2017
Q2 | $33.2K | Buy |
1,217
+780
| +178% | +$21.3K | ﹤0.01% | 3393 |
|
|
2017
Q1 | $14.5K | Buy |
437
+276
| +171% | +$7.03K | ﹤0.01% | 3102 |
|
|
2016
Q4 | $3.84K | Sell |
161
-490
| -75% | -$14K | ﹤0.01% | 3794 |
|
|
2016
Q3 | $23.9K | Buy |
651
+289
| +80% | +$8.29K | ﹤0.01% | 2789 |
|
|
2016
Q2 | $8.06K | Buy |
+362
| New | +$9K | ﹤0.01% | 3023 |
|
|
2016
Q1 | – | Sell |
-1,690
| Closed | -$51.2K | – | 3005 |
|
|
2015
Q4 | $51.2K | Sell |
1,690
-187
| -10% | -$5.67K | ﹤0.01% | 2797 |
|
|
2015
Q3 | $46.4K | Buy |
1,877
+1,144
| +156% | +$34.1K | ﹤0.01% | 2921 |
|
|
2015
Q2 | $23.5K | Buy |
733
+526
| +254% | +$20.1K | ﹤0.01% | 2944 |
|
|
2015
Q1 | $7.39K | Buy |
+207
| New | +$5.68K | ﹤0.01% | 2925 |
|
|
2014
Q4 | – | Sell |
-520
| Closed | -$10.1K | – | 2940 |
|
|
2014
Q3 | $10.1K | Buy |
+520
| New | +$14.7K | ﹤0.01% | 3585 |
|
|
2014
Q1 | – | Sell |
-113
| Closed | -$3.22K | – | 3736 |
|
|
2013
Q4 | $3.22K | Sell |
113
-2,266
| -95% | -$66.5K | ﹤0.01% | 3379 |
|
|
2013
Q3 | $85.2K | Sell |
2,379
-516
| -18% | -$18.8K | ﹤0.01% | 2443 |
|
|
2013
Q2 | $96.7K | Buy |
+2,895
| New | +$131K | ﹤0.01% | 2537 |
|
Other funds holding RIGL
SCM
AC
BNP Paribas Financial Markets's RIGL Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Rigel Pharmaceuticals (RIGL) stake by 45% in Q2 2026, selling an estimated $87.3K and leaving 3,423 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #4393.
BNP Paribas Financial Markets first reported a position in RIGL in Q2 2013 and has held it in 49 quarters since. The position peaked at $555K in Q1 2025. 146 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.
- BNP Paribas Financial Markets held 3,423 shares of Rigel Pharmaceuticals worth $134K as of Q2 2026.
- BNP Paribas Financial Markets sold 2,832 Rigel Pharmaceuticals shares in Q2 2026, an estimated $87.3K.
- Rigel Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4393 holding.
- BNP Paribas Financial Markets first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- BNP Paribas Financial Markets's Rigel Pharmaceuticals position peaked at $555K in Q1 2025.
- 146 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.